BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Ischemia
,
Prostate
,
Personalized medicine
,
Clofibrate
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RPL 7
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for RPL 7
Explore Curated Studies Results
Literature
Most Relevant Literature
Functional significance of point mutations in stress chaperone mortalin and their relevance to Parki…
Ribosomal protein L7 as a suitable reference gene for quantifying gene expression in gastropod Bella…
Control of phosphate release from elongation factor G by ribosomal protein L7/12.
Interaction of the G' domain of elongation factor G and the C-terminal domain of ribosomal protein L…
Validation of housekeeping genes as internal controls for studying gene expression during Pacific oy…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
2.Comparison of the Live Birth Rate of PGT Versus Expectant Management in Patients With RPL
An Randomized Double Blind Controlled Trial of niPGT-A in Women With RPL
Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in…
A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexp…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ